Quit Nits Preventative

Manufacturer
Wild Child W A Pty Ltd | Triad Group
Effective date
2009-10-28
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 02:02:56

Label at a glance#

ProductQuit Nits Preventative
Active ingredienteucalyptus globulus leaf
Label structure9 sections

Dosage and administration

Apply On the day following the lice treatment lightly spray Quit Nits Preventative onto dry hair until the hair is damp Comb Use a regular comb or brush to distribute Quit Nits Preventative evenly throughout the hair Repeat For best results, repeat daily or before children play with untreated children

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS

OTC - ACTIVE INGREDIENT SECTION

Eucalyptus globulus 1X (Tasmanian Blue Gum 1mg/g)

PURPOSE

OTC - PURPOSE SECTION

Lice prevention

USE

INDICATIONS & USAGE SECTION

repels head lice

WARNINGS

WARNINGS SECTION

Not for use if live lice are detected, use Quit Nits treatment first.

For external use only.

DO NOT USE

OTC - DO NOT USE SECTION

  • near eyes
  • inside the nose, mouth or vagina
  • on lice in eyebrows or eyelashes

See a doctor if lice are present in these areas.

OTC - ASK DOCTOR SECTION


OTC - ASK DOCTOR/PHARMACIST SECTION

WHEN USING THIS PRODUCT

OTC - WHEN USING SECTION

  • keep tightly closed and protect eyes with a washcloth or towel.
  • if product gets into the eyes, flush with water right away.

STOP USE AND ASK A DOCTOR IF

OTC - STOP USE SECTION

  • eye irritation occurs
  • skin or scalp irritation continues or infection occurs

WARNINGS SECTION

OTC - PREGNANCY OR BREAST FEEDING SECTION

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Apply
On the day following the lice treatment lightly spray Quit Nits Preventative onto dry hair until the hair is damp

Comb
Use a regular comb or brush to distribute Quit Nits Preventative evenly throughout the hair

Repeat
For best results, repeat daily or before children play with untreated children

OTHER INFORMATION

SPL UNCLASSIFIED SECTION

  • keep carton for important product information
  • protect from excessive heat

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION


aqua, polysorbate 20, acetum, alcohol, fragrance, geranium oil, simethicone, cetrimonium chloride, lavandula angustifolia, fusanus spicatus

QUESTIONS

OTC - QUESTIONS SECTION

800-961-4936 or

support@QuitNits.com

www.QuitNits.com

PACKAGING INFORMATION

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Quit Nits®
Homeopathic Everyday Head Lice Preventative Spray

Certified Natural Active Ingredients

Use daily to stop lice re-infestation

Spray application
Non-toxic
Scientifically Proven
Homeopathic

WILD CHILD®
Born, not made.

4.2 FL. OZ (125 ml)

Up to 8 hours protection for
  • children
  • hats/clothes
  • bedding
  • toys
Caring for your child, naturally
  • Contains natural essential oils
  • No chemical pesticides
  • Pleasant fragrance
  • Low allergy formulation
WILD CHILD® has become a world presence in natural health care for children. Founded by mother of three, Leanne Preston, in Margaret River, Australia, Wild Child aims to bridge the gap between traditional and homeopathic medicines.

Leanne Preston , Founder
"
We believe that Wild Child's acknowledgment of our need to exist as part of nature, our hopes for the world and our responsibility to its children are the reasons for our being and the motivations for our growth."

WILD CHILD®
Born, not made.

Does NOT Contain: Chemical preservatives, artificial colors or fragrances, sodium lauryl or laureth sulfate, propylene glycol, parabens, mineral oils or genetically modified ingredients.

Manufactured for:
Wild Child (US) Pty Ltd
by The Triad Group
700 West North Shore Drive
Hartland, WI 53029
support@QuitNits.com
800.961.4936

Product of USA
Not tested on animals.

carton
carton



DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
48747306-602a-42cc-957b-5b0c69158eeeProduct name120180604
db5ebcdb-b6ae-21cd-4dc5-76cd84b5578bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
30807-3003-42025-10-29C16284748780-1956f9ecf-cdd7-621f-e053-dbdaa90a74adDRUG FACTS
30807-3003-42019-10-21C16284748780-1956f9ecf-cdd7-621f-e053-dbdaa90a74adDRUG FACTS

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
30807-3003QUIT NITS PREVENTATIVE (EUCALYPTUS GLOBULUS) SPRAY [WILD CHILD W A PTY LTD]2Legacy NDC20110113_c0043a16-b07c-415c-8485-f3d881e9700f.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
eucalyptus globulus leafACTIVE INGREDIENTS546YLW6E62
eucalyptus globulus leafACTIVE MOIETYS546YLW6E62
acetic acidINACTIVE INGREDIENTQ40Q9N063P2
alcoholINACTIVE INGREDIENT3K9958V90M2
cetrimonium chlorideINACTIVE INGREDIENTUC9PE95IBP2
dimethiconeINACTIVE INGREDIENT92RU3N3Y1O2
polysorbate 20INACTIVE INGREDIENT7T1F30V5YH2
waterINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
30807-300330807-3003-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 132 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
alcoholALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PSOLUTION / ORAL10 mgExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSWAB / TOPICAL2250 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MCAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION / INTRASYNOVIALADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHINJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR60 mgExact identifier — unii candidate
28 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHSOLUTION / TOPICAL15 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLIQUID / INTRAMUSCULAR400 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MDROPS / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PLIQUID / SUBCUTANEOUS0.2 %w/vExact identifier — unii candidate
45 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHTABLET / ORAL17 mgExact identifier — unii candidate
28 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHTABLET, FILM COATED / ORAL0.35 mgExact identifier — unii candidate
28 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PSOLUTION / INTRAVENOUS14 mgExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSHAMPOO / TOPICAL714 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION, CONCENTRATE / ORAL150.68 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / DENTAL12.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MCONCENTRATE / BUCCAL679 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHAEROSOL, FOAM / VAGINAL3 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION, SOLUTION / SUBCUTANEOUS4 mgExact identifier — unii candidate
45 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION, EMULSION / INTRAVENOUSADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PSOLUTION/ DROPS / OPHTHALMIC0.09 %w/vExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PELIXIR / ORAL1.07 mg/5mlExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / TOPICAL2445 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, METERED / NASAL70 mgExact identifier — unii candidate
59 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHTAMPON / VAGINAL64.8 mgExact identifier — unii candidate
28 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHINJECTION, SOLUTION / INTRAVENOUS30 mgExact identifier — unii candidate
28 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUSADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MLOTION / TOPICAL25 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION, CONCENTRATE / INTRAVENOUS4000 mgExact identifier — unii candidate
59 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
28 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PSUSPENSION / ENDOTRACHEALADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MMOUTHWASH / BUCCAL200 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHTABLET, EXTENDED RELEASE / ORAL4.2 mgExact identifier — unii candidate
28 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION / INTRA-ARTICULARADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSUSPENSION / RECTAL0.35 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHCAPSULE / ORAL563 mgExact identifier — unii candidate
28 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PSOLUTION / TOPICALADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHEMULSION / TOPICAL2 %w/wExact identifier — unii candidate
28 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION / INTRAMUSCULAR1491 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / INTRAVENOUS99 mgExact identifier — unii candidate
59 equally ranked IID candidates
alcoholALCOHOL3K9958V90MTABLET, DELAYED RELEASE / ORALNAExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PCAPSULE, COATED / ORAL1 mgExact identifier — unii candidate
45 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION, SOLUTION / SUBMUCOSALADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION, EMULSION / INTRAMUSCULARADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MINJECTION / INTRAVENOUS92 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION / INTRALESIONALADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PLIQUID / INTRAVENOUS0.2 %w/vExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PSUSPENSION/ DROPS / AURICULAR (OTIC)0.04 %w/vExact identifier — unii candidate
45 equally ranked IID candidates
alcoholALCOHOL3K9958V90MSOLUTION / RESPIRATORY (INHALATION)0.08 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
acetic acidACETIC ACIDQ40Q9N063PINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULARADJ PHExact identifier — unii candidate
45 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHSUSPENSION / OPHTHALMIC0.05 %w/vExact identifier — unii candidate
28 equally ranked IID candidates
polysorbate 20POLYSORBATE 207T1F30V5YHCREAM / TOPICAL108 mgExact identifier — unii candidate
28 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3b021e48-3f09-e26a-e063-6294a90a1d68c0043a16-b07c-415c-8485-f3d881e9700f2025-07-28WarningsExact identifier
spl set id: c0043a16-b07c-415c-8485-f3d881e9700f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.